175 related articles for article (PubMed ID: 37195077)
1. Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1.
Lasarte-Monterrubio C; Guijarro-Sánchez P; Vázquez-Ucha JC; Alonso-Garcia I; Alvarez-Fraga L; Outeda M; Martinez-Guitian M; Peña-Escolano A; Maceiras R; Lence E; González-Bello C; Arca-Suárez J; Bou G; Beceiro A
Antimicrob Agents Chemother; 2023 May; 67(5):e0150522. PubMed ID: 37195077
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
3.
Huang YS; Chen PY; Chou PC; Wang JT
Microbiol Spectr; 2023 Jun; 11(3):e0056923. PubMed ID: 37154758
[TBL] [Abstract][Full Text] [Related]
4. Genomic Modification of TonB and Emergence of Small-Colony Phenotype in VIM- and NDM-Producing Escherichia coli following Cefiderocol Exposure
Kocer K; Boudour-Halil D; Chanthalangsy Q; Sähr A; Heeg K; Boutin S; Nurjadi D
Antimicrob Agents Chemother; 2023 May; 67(5):e0011823. PubMed ID: 37022155
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains.
Kohira N; West J; Ito A; Ito-Horiyama T; Nakamura R; Sato T; Rittenhouse S; Tsuji M; Yamano Y
Antimicrob Agents Chemother; 2016 Feb; 60(2):729-34. PubMed ID: 26574013
[TBL] [Abstract][Full Text] [Related]
6. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
[TBL] [Abstract][Full Text] [Related]
7. Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Ito A; Nishikawa T; Ota M; Ito-Horiyama T; Ishibashi N; Sato T; Tsuji M; Yamano Y
J Antimicrob Chemother; 2018 Nov; 73(11):3049-3052. PubMed ID: 30188999
[TBL] [Abstract][Full Text] [Related]
8. New Delhi Metallo-Beta-Lactamase Facilitates the Emergence of Cefiderocol Resistance in Enterobacter cloacae.
Nurjadi D; Kocer K; Chanthalangsy Q; Klein S; Heeg K; Boutin S
Antimicrob Agents Chemother; 2022 Feb; 66(2):e0201121. PubMed ID: 34871093
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates.
Zhang Q; Neidig N; Chu TY; Divoky C; Carpenter J; Lee-Hsiao C; Threatt H; Sultana R; Bush K
Diagn Microbiol Infect Dis; 2022 May; 103(1):115651. PubMed ID: 35228130
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of High Levels of Cefiderocol Resistance in Carbapenem-Resistant Escherichia coli before Its Approval in China: a Report from China CRE-Network.
Wang Q; Jin L; Sun S; Yin Y; Wang R; Chen F; Wang X; Zhang Y; Hou J; Zhang Y; Zhang Z; Luo L; Guo Z; Li Z; Lin X; Bi L; Wang H
Microbiol Spectr; 2022 Jun; 10(3):e0267021. PubMed ID: 35481835
[TBL] [Abstract][Full Text] [Related]
11. Detection of VIM-1-Producing Enterobacter cloacae and Salmonella enterica Serovars Infantis and Goldcoast at a Breeding Pig Farm in Germany in 2017 and Their Molecular Relationship to Former VIM-1-Producing
Roschanski N; Hadziabdic S; Borowiak M; Malorny B; Tenhagen BA; Projahn M; Kaesbohrer A; Guenther S; Szabo I; Roesler U; Fischer J
mSphere; 2019 Jun; 4(3):. PubMed ID: 31189558
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia.
Alzayer M; Alghoribi MF; Alalwan B; Alreheli A; Aljohani S; Bosaeed M; Doumith M
J Glob Antimicrob Resist; 2023 Mar; 32():176-180. PubMed ID: 36481491
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
Gill CM; Santini D; Nicolau DP;
J Antimicrob Chemother; 2024 Feb; 79(2):412-416. PubMed ID: 38153232
[TBL] [Abstract][Full Text] [Related]
14. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
[TBL] [Abstract][Full Text] [Related]
15. Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA.
Klein S; Boutin S; Kocer K; Fiedler MO; Störzinger D; Weigand MA; Tan B; Richter D; Rupp C; Mieth M; Mehrabi A; Hackert T; Zimmermann S; Heeg K; Nurjadi D
Clin Infect Dis; 2022 Mar; 74(5):905-908. PubMed ID: 34079986
[TBL] [Abstract][Full Text] [Related]
16.
Mushtaq S; Sadouki Z; Vickers A; Livermore DM; Woodford N
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958717
[TBL] [Abstract][Full Text] [Related]
17. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
18.
Delgado-Valverde M; Portillo-Calderón I; Recacha E; Pérez-Palacios P; Pascual A
Microbiol Spectr; 2023 Jun; 11(3):e0493622. PubMed ID: 37249425
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain).
Treviño M; Moldes L; Martínez-Lamas L; Varón C; Regueiro BJ
Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1253-8. PubMed ID: 19504135
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Miltgen G; Bonnin RA; Avril C; Benoit-Cattin T; Martak D; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Filleul L; Subiros M; de Montera AM; Cholley P; Thouverez M; Dortet L; Bertrand X; Naas T; Hocquet D; Belmonte O
Int J Antimicrob Agents; 2018 Sep; 52(3):416-420. PubMed ID: 29807164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
